Safety and Immunogenicity of a Melan-A VLP Vaccine in Advanced Stage Melanoma Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
The purpose of this study is to evaluate whether vaccination with a Melan-A VLP vaccine leads to a specific cellular immune response in patients with malignant melanoma at advanced stage of the disease.
Epistemonikos ID: 6fd848e94ae841b4137cb56072dfa66a236c6920
First added on: May 04, 2024